Long QT and stroke

Cerebrovascular Diseases

Volumn 22, Issue 5-6, 2006, Pages 461-

  Röggla, Georg ^a,c   Moser, Bernadetta ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b General Hospital of Bozen   (Italy)

^c Abteilung für Innere Medizin   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT;

ACUTE HEART INFARCTION; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HEART DISEASE; HUMAN; INSULA; LETTER; MORTALITY; PREDICTION; PRIORITY JOURNAL; QT PROLONGATION; RISK FACTOR; STROKE;

CARDIOVASCULAR DISEASES; CEREBROVASCULAR ACCIDENT; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LONG QT SYNDROME; MALE; RISK FACTORS;

EID: 33750586931     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096290     Document Type: Letter

References (6)

1. Tatschl C, Stollberger C, Matz K, Yilmaz N, Eckhardt R, Nowotny M, Dachenhausen A, Brainin M: Insular involvement is associated with QT prolongation: ECG abnormalities in patients with acute stroke. Cerebrovasc Dis 2006;21:47-53.
2. Anderson ME: QT interval prolongation and arrhythmia: an unbreakable connection? J Intern Med 2006;259:81-90.
3. Schouten EG, Dekker JM, Meppelink P, Kok FJ, Vandenbroucke JP, Pool J: QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation 1991;84:1516-1523.
4. Viskin S: Long QT syndromes and torsade de pointes. Lancet 1999;354: 1625-1633.
5. Davenport RJ, Dennis MS, Wellwood I, Warlow CP: Complications after acute stroke. Stroke 1996;27:415-420.
6. EUSI Stroke recommendations: http://www.eusi-stroke.com/l3_pdf/Eusi- Flyer%202003.pdf.